mRNA |
BIBR-1532 |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
WZ8040 |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
istradefylline |
CTRPv2 |
pan-cancer |
AAC |
0.027 |
0.6 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.6 |
mRNA |
5-FU |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.6 |
mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
0.023 |
0.6 |
mRNA |
skepinone-L |
CTRPv2 |
pan-cancer |
AAC |
0.025 |
0.6 |
mRNA |
tandutinib |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.6 |
mRNA |
cabozantinib |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.6 |